Skip to main content
SpringerLink
Log in

Nierenbecken- und Harnleiterkarzinom

  • Chapter
  • First Online:
Uroonkologie

  • 2838 Accesses

Zusammenfassung

Bei den Urothelkarzinomen werden Tumoren des unteren Harntraktes (Harnblase, Urethra) von Tumoren des oberen Harntraktes (Nierenbecken und Ureter) unterschieden. Das Auftreten korreliert mit der urothelialen Oberfläche: ca. 90–95% der Urothelkarzinome sind in der Harnblase und ca. 5–10% im oberen Harntrakt lokalisiert. Dieser Beiträg beschäftigt sich mit den Nierenbeckenkarzinomen sowohl als auch mit den Harnleiterkarzinomen im Hinblick auf Risikofaktoren, Diagnose, onkologische Kennzeichen, Therapie, Prognose und Nachsorge.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 76: 895–901

    PubMed  Google Scholar 

  • Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH (2007) Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 28: 2253–2261

    CAS  PubMed  Google Scholar 

  • Audenet F, Yates DR, Cussenot O, Rouprêt M (2010) The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). Urol Oncol (Epub ahead of print)

    Google Scholar 

  • Azémar MD, Comperat E, Richard F, Cussenot O, Rouprêt M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29: 130–136

    PubMed  Google Scholar 

  • Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J (2008) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54: 303–314

    PubMed  Google Scholar 

  • Bagley DH, Grasso M 3rd (2010) Ureteroscopic laser treatment of upper urinary tract neoplasms. World J Urol 28: 143–149

    PubMed  Google Scholar 

  • Berger A, Haber GP, Kamoi K, Aron M, Desai MM, Kaouk JH, Gill IS (2008) Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. J Urol 180: 849–954

    PubMed  Google Scholar 

  • Bolenz C, Shariat SF, Fernández MI, Margulis V, Lotan Y, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Montorsi F, Bensalah K, Wood CG, Roscigno M, Langner C, Koppie TM, Raman JD, Mikami S, Michel MS, Ströbel P (2009) Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 103: 302–306

    PubMed  Google Scholar 

  • Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184: 69–73

    PubMed  Google Scholar 

  • Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF (2006) Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int 98: 1176–1180

    PubMed  Google Scholar 

  • Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF (2006) Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology.67: 518–523

    PubMed  Google Scholar 

  • Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Fernández MI, Ströbel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56: 1–9

    PubMed  Google Scholar 

  • Catto JW, Azzouzi AR, Amira N, Rehman I, Feeley KM, Cross SS, Fromont G, Sibony M, Hamdy FC, Cussenot O, Meuth M (2003) Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene 22: 8699–8706

    CAS  PubMed  Google Scholar 

  • Chen GL, Bagley DH (2000) Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 164: 1173–1176

    CAS  PubMed  Google Scholar 

  • Chen GL, El-Gabry EA, Bagley DH (2000) Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. J Urol 164: 1901–1904

    CAS  PubMed  Google Scholar 

  • Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61: 245–253

    PubMed  Google Scholar 

  • Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, Rouprêt M (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104: 1436–1440

    CAS  PubMed  Google Scholar 

  • Cornu JN, Rouprêt M, Carpentier X, Geavlete B, de Medina SG, Cussenot O, Traxer O (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28:151–156

    PubMed  Google Scholar 

  • Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172: 1271–1275

    CAS  PubMed  Google Scholar 

  • Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98: 55–60

    PubMed  Google Scholar 

  • Dillman JR, Caoili EM, Cohan RH, Ellis JH, Francis IR, Schipper MJ (2008) Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography. Abdom Imaging 33: 707–716

    PubMed  Google Scholar 

  • Eltz S, Comperat E, Cussenot O, Rouprêt M (2008) Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102: 532–535

    CAS  PubMed  Google Scholar 

  • Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G (2010a) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58: 574–580

    Google Scholar 

  • Favaretto RL, Shariat SF, Chade DC, Godoy G, Kaag M, Cronin AM, Bochner BH, Coleman J, Dalbagni G (2010b) Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58: 645–651

    Google Scholar 

  • Fernández MI, Shariat SF, Margulis V, Bolenz C, Montorsi F, Suardi N, Remzi M, Wood CG, Roscigno M, Kikuchi E, Oya M, Zigeuner R, Langner C, Weizer A, Lotan Y, Koppie TM, Raman JD, Karakiewicz P, Bensalah K, Schultz M, Bernier P (2009) Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology 73: 142–146

    PubMed  Google Scholar 

  • Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183: 2148–2153

    PubMed  Google Scholar 

  • Girish G, Chooi WK, Morcos SK (2004) Filling defect artefacts in magnetic resonance urography. Eur Radiol 14: 145–150

    CAS  PubMed  Google Scholar 

  • Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelaković B (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104: 12129–12134

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hall MC, Womack JS, Roehrborn CG, Carmody T, Sagalowsky AI (1998a) Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol 160: 703–706

    CAS  Google Scholar 

  • Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998b) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52: 594–601

    CAS  Google Scholar 

  • Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP, Koppie TM (2009) Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 182: 900–906

    PubMed  Google Scholar 

  • Holmäng S, Johansson SL (2004) Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 101: 741–7

    PubMed  Google Scholar 

  • Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S (2002) Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology 59: 53–57

    PubMed  Google Scholar 

  • Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI (2009) Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 182: 2177–2181

    PubMed  Google Scholar 

  • Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Kubota K, Matsuno Y, Osawa T, Shinno Y, Kumagai A, Togashi M, Matsuda H, Mori T, Nonomura K (2010) Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 184: 883–887

    PubMed  Google Scholar 

  • Jakse G (2009) Nierenbecken- und Harnleiterkarzinom. In: Rübben H (Hrsg) Uroonkologie, 5. Aufl, Springer Medizin Verlag, Heidelberg, S 371–394

    Google Scholar 

  • Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budaus L, Lattouf JB, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI (2010) Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol 183: 1324–1329

    PubMed  Google Scholar 

  • Jeldres C, Sun M, Isbarn H, Lughezzani G, Budäus L, Alasker A, Shariat SF, Lattouf JB, Widmer H, Pharand D, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI (2010) A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology 75: 315–320

    PubMed  Google Scholar 

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009, CA Cancer J Clin 59: 225–249

    PubMed  Google Scholar 

  • Kaag MG, O’Malley RL, O’Malley P, Godoy G, Chen M, Smaldone MC, Hrebinko RL, Raman JD, Bochner B, Dalbagni G, Stifelman MD, Taneja SS, Huang WC (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58: 581–587

    PubMed Central  PubMed  Google Scholar 

  • Kamihira O, Hattori R, Yamaguchi A, Kawa G, Ogawa O, Habuchi T, Kawauchi A, Uozumi J, Yokoi S, Tsujihata M, Hasui Y, Miyakoda K, Tada H, Ono Y, Naito S (2009) Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol 55: 1397–1407

    PubMed  Google Scholar 

  • Kawashima A, Glockner JF, King BF Jr (2003) CT urography and MR urography. Radiol Clin North Am 41: 945–961

    PubMed  Google Scholar 

  • Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE (2000) A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 163: 524–527

    CAS  PubMed  Google Scholar 

  • Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, Montorsi F, Bensalah K, Koppie TM, Fernández MI, Raman JD, Kassouf W, Wood CG, Suardi N, Oya M, Shariat SF (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27: 612–618

    PubMed Central  PubMed  Google Scholar 

  • Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47: 155–169

    PubMed  Google Scholar 

  • Laing C, Hamour S, Sheaff M, Miller R, Woolfson R (2006) Chinese herbal uropathy and nephropathy. Lancet 368: 338

    PubMed  Google Scholar 

  • Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D, Dreicer R, Hansel DE, Stephenson AJ (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116: 2967–2973

    PubMed  Google Scholar 

  • Lee TY, Ko SF, Wan YL, Cheng YF, Yang WC, Hsieh HH, Chen WJ, Eng HL (1997) Unusual imaging presentations in renal transitional cell carcinoma. Acta Radiol 38: 1015–1019

    CAS  PubMed  Google Scholar 

  • Lee KS, Zeikus E, DeWolf WC, Rofsky NM, Pedrosa I (2010) MR urography versus retrograde pyelography/ureteroscopy for the exclusion of upper urinary tract malignancy. Clin Radiol 65: 185–192

    CAS  PubMed  Google Scholar 

  • Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182: 451–458

    PubMed  Google Scholar 

  • Li WM, Shen JT, Li CC, Ke HL, Wei YC, Wu WJ, Chou YH, Huang CH (2010) Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57: 963–969

    PubMed  Google Scholar 

  • Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R (2004) Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 45: 257–266

    PubMed  Google Scholar 

  • Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD (2001) Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358: 1515–6

    CAS  PubMed  Google Scholar 

  • Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Sun M, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI (2010a) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75: 118–124

    Google Scholar 

  • Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L, Alasker A, Duclos A, Widmer H, Latour M, Guazzoni G, Montorsi F, Karakiewicz PI (2010b) Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol 57: 956–962

    Google Scholar 

  • Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, Latour M, Widmer H, Duclos A, Bénard F, McCormack M, Montorsi F, Karakiewicz PI (2010c) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology 75: 321–327

    Google Scholar 

  • Luo B, Li W, Deng CH, Zheng FF, Sun XZ, Wang DH, Dai YP (2009) Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet 189: 93–97

    CAS  PubMed  Google Scholar 

  • Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348: 919–932

    CAS  PubMed  Google Scholar 

  • Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115: 1224–1233

    PubMed  Google Scholar 

  • Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Shariat SF (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184: 453–458

    PubMed  Google Scholar 

  • Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A (1998) The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 141: 350–355

    Google Scholar 

  • Markovic N, Ignjatovic I, Cukuranovic R, Petrovic B, Kocic B, Stefanovic V (2005) Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998. Pathol Biol (Paris). 53: 26–29

    Google Scholar 

  • Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA, Dinney CP, Millikan R, Siefker-Radtke AO (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116: 3127–3134

    PubMed  Google Scholar 

  • Matthew DR (1985) Ultrasonography of the lower genitorurinary tract. Urologic Clin North Am 12/4: 645–656

    Google Scholar 

  • Mian C, Mazzoleni G, Vikoler S, Martini T, Knüchel-Clark R, Zaak D, Lazica A, Roth S, Mian M, Pycha A (2010) Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours. Eur Urol 58: 288–292

    PubMed  Google Scholar 

  • Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164: 1523–1525

    CAS  PubMed  Google Scholar 

  • Murakami S, Igarashi T, Hara S, Shimazaki J (1990) Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. J Urol 144: 99–101

    CAS  PubMed  Google Scholar 

  • Ng CK, Shariat SF, Lucas SM, Bagrodia A, Lotan Y, Scherr DS, Raman JD (2011) Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol 29: 27–32

    PubMed  Google Scholar 

  • Nonomura N, Ono Y, Nozawa M, Fukui T, Harada Y, Nishimura K, Takaha N, Takahara S, Okuyama A (2000) Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol 38: 701–704

    CAS  PubMed  Google Scholar 

  • Novara G, De Marco V, Dalpiaz O, Galfano A, Bouygues V, Gardiman M, Martignoni G, Patard JJ, Artibani W, Ficarra V (2009) Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Int J Urol 16: 187–191

    PubMed  Google Scholar 

  • Olgac S, Mazumdar M, Dalbagni G, Reuter VE (2004) Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 28: 1545–1552

    PubMed  Google Scholar 

  • Ong AM, Bhayani SB, Pavlovich CP (2003) Trocar site recurrence after laparoscopic nephroureterectomy. J Urol 170: 1301

    PubMed  Google Scholar 

  • Oosterlinck W, Solsona E, van der Meijden AP, Sylvester R, Böhle A, Rintala E, Lobel B (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46:147–154

    CAS  PubMed  Google Scholar 

  • Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Orsola I (2005) Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma. Urology 65: 49–54

    CAS  PubMed  Google Scholar 

  • Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol 29: 487–494

    PubMed  Google Scholar 

  • Palou J, Piovesan LF, Huguet J, Salvador J, Vicente J, Villavicencio H (2004) Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol 172: 66–69

    PubMed  Google Scholar 

  • Perez-Montiel D, Wakely PE, Hes O, Michal M, Suster S (2006) High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 19: 494–503

    PubMed  Google Scholar 

  • Phé V, Cussenot O, Bitker MO, Rouprêt M (2011) Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? BJU Int 108: 130–138

    PubMed  Google Scholar 

  • Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Pizá P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106: 1319–1323

    PubMed  Google Scholar 

  • Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27: 289–293

    PubMed Central  PubMed  Google Scholar 

  • Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M (1999) Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 14: 2892–2897

    CAS  PubMed  Google Scholar 

  • Rajput MZ, Kamat AM, Clavell-Hernandez J, Siefker-Radtke AO, Grossman HB, Dinney CP, Matin SF (2011) Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Urology 78: 61–67

    PubMed Central  PubMed  Google Scholar 

  • Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS (2005) Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 96: 1031–1035

    PubMed  Google Scholar 

  • Raman JD, Ng CK, Scherr DS, Margulis V, Lotan Y, Bensalah K, Patard JJ, Kikuchi E, Montorsi F, Zigeuner R, Weizer A, Bolenz C, Koppie TM, Isbarn H, Jeldres C, Kabbani W, Remzi M, Waldert M, Wood CG, Roscigno M, Oya M, Langner C, Wolf JS, Ströbel P, Fernández M, Karakiewcz P, Shariat SF (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 57: 1072–1079

    PubMed  Google Scholar 

  • Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29: 716–723

    PubMed  Google Scholar 

  • Rassweiler JJ, Schulze M, Marrero R, Frede T, Palou Redorta J, Bassi P (2004) Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol 46: 690–697

    PubMed  Google Scholar 

  • Remzi M, Haitel A, Margulis V, Karakiewicz P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103: 307–311

    PubMed  Google Scholar 

  • Remzi M, Nader A (2010) Leitlinie Urothelkarzinom des oberen Harntrakts. Journal für Urologie und Urogynäkologie 17: 31–32

    Google Scholar 

  • Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F (2009a) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181: 2482–2489

    Google Scholar 

  • Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Sagalowsky A, Bensalah K, Raman JD, Bolenz C, Kassou W, Koppie TM, Wood CG, Wheat J, Langner C, Ng CK, Capitanio U, Bertini R, Fernández MI, Mikami S, Isida M, Ströbel P, Montorsi F (2009b) The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56: 512–518

    Google Scholar 

  • Rouprêt M, Catto J, Coulet F, Azzouzi AR, Amira N, Karmouni T, Fromont G, Sibony M, Vallancien G, Gattegno B, Meuth M, Hamdy FC, Cussenot O (2004) Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma. J Med Genet 41: 91

    Google Scholar 

  • Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O (2005) Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 65: 1233–1237

    PubMed  Google Scholar 

  • Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67: 1181–1187

    PubMed  Google Scholar 

  • Rouprêt M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, Vallancien G, Rozet F (2007) Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology 69: 656–661

    PubMed  Google Scholar 

  • Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F, Cussenot O (2007) Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51: 709–713

    PubMed  Google Scholar 

  • Rouprêt M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol 54: 1226–1236

    PubMed  Google Scholar 

  • Rouprêt M, Smyth G, Irani J, Guy L, Davin JL, Saint F, Pfister C, Wallerand H, Rozet F (2009) Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol 27: 81–88

    PubMed  Google Scholar 

  • Rouprêt M, Wallerand H, Traxer O, Roy C, Mazerolles C, Saint F, Quintens H, Amsellem-Ouazana D, Bernardini S, Guy L, Soulié M, Pfister C (2010) Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology. Prog Urol 20: 260–271

    PubMed  Google Scholar 

  • Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011 59: 584–594

    PubMed  Google Scholar 

  • Rübben H, Sökeland J, Schulze H (2004) Harnblasenkarzinom. In: Sökeland J, Schulze H, Rübben H (Hrsg.) Urologie, Verstehen – Lernen – Anwenden, 13. Auflage, Stuttgart, New York,: Thieme S 266–273

    Google Scholar 

  • Saika T, Nishiguchi J, Tsushima T, Nasu Y, Nagai A, Miyaji Y, Maki Y, Akaeda T, Saegusa M, Kumon H (2004) Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis. Urology 63: 848–852

    PubMed  Google Scholar 

  • Sauter G, Algaba F, Amin M, et al (2004) Tumors of the urinary system. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, (Hrsg) World Health Organization classification of tumours: pathology and genetics of tumors of the urinary system and male genital organs. Lyon, France: IARC Pressp. S 110–123

    Google Scholar 

  • Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G (2010) Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol 184: 1895–1900

    PubMed  Google Scholar 

  • Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Wheat JC, Zigeuner R, Langner C, Wood CG, Margulis V (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105: 1672–1677

    PubMed  Google Scholar 

  • Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 29: 481–486

    PubMed  Google Scholar 

  • Shariat SF, Zigeuner R, Rink M, Margulis V, Hansen J, Kikuchi E, Kassouf W, Raman JD, Remzi M, Koppie TM, Bensalah K, Guo CC, Mikami S, Sircar K, Ng CK, Haitel A, Kabbani W, Chun FK, Wood CG, Scherr DS, Karakiewicz PI, Langner C (2012) Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification. Eur Urol (Epub ahead of print)

    Google Scholar 

  • Shinka T, Miyai M, Sawada Y, Inagaki T, Okawa T (1995) Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int J Urol 2: 243–248

    CAS  PubMed  Google Scholar 

  • Sijmons RH, Kiemeney LA, Witjes JA, Vasen HF (1998) Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol 160: 466–470

    CAS  PubMed  Google Scholar 

  • Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, Gallucci M (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56: 520–526

    PubMed  Google Scholar 

  • Sobin L, Gospodarowicz M, Wittekind C (Hrsg) (2009) Renal pelvis and ureter. In: TNM classification of malignant tumours. Urological tumours. International Union Against Cancer. Ed 7 rev. New York, NY: Wiley-Blackwell, S 258–261

    Google Scholar 

  • Stewart GD, Bariol SV, Grigor KM, Tolley DA, McNeill SA (2005) A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int 95: 791–793

    PubMed  Google Scholar 

  • Subramanyam BF, Raghavendra BN, Madamba MR (1982) Renal transitional-cell carcinoma: sonographic and pathologic correlation. J Clin Ultrasound 10: 203–210

    CAS  PubMed  Google Scholar 

  • Takahashi N, Kawashima A, Glockner JF, Hartman RP, Leibovich BC, Brau AC, Beatty PJ, King BF (2008) Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology 247: 451–457

    PubMed  Google Scholar 

  • Takahashi N, Glockner JF, Hartman RP, King BF, Leibovich BC, Stanley DW, Fitz-Gibbon PD, Kawashima A (2010) Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol 183: 1330–1365

    PubMed  Google Scholar 

  • Tan LB, Chen KT, Guo HR (2008) Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan. BJU Int 102: 48–54

    PubMed  Google Scholar 

  • Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, Epstein JI (2009) Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol 33: 1540–1546

    PubMed  Google Scholar 

  • Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M (2008) Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 71: 123–127

    PubMed  Google Scholar 

  • Thalmann GN, Markwalder R, Walter B, Studer UE (2002) Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168: 1381–1385

    PubMed  Google Scholar 

  • Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML (2008) Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJU Int 102: 1107–1110

    PubMed  Google Scholar 

  • Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, Nolte-Ernsting CC, Takahashi S, Cohan RH (2008) CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol 18: 4–17

    Google Scholar 

  • Verswijvel GA, Oyen RH, Van Poppel HP, Goethuys H, Maes B, Vaninbrouckx J, Bosmans H, Marchal G (2000) Magnetic resonance imaging in the assessment of urologic disease: an all-in-one approach. Eur Radiol 10: 1614–1619

    CAS  PubMed  Google Scholar 

  • Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST (2009) Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181: 524–531

    PubMed  Google Scholar 

  • Wang LJ, Wong YC, Huang CC, Wu CH, Hung SC, Chen HW (2010) Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol 183: 48–55

    PubMed  Google Scholar 

  • Watson P, Lynch HT (1994) The tumor spectrum in HNPCC. Anticancer Res 14: 1635–1639

    CAS  PubMed  Google Scholar 

  • Wheat JC, Weizer AZ, Wolf JS Jr, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF (2010) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol (Epub ahead of print)

    Google Scholar 

  • Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W (2011) Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int (Epub ahead of print)

    Google Scholar 

  • Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53: 720–731

    PubMed  Google Scholar 

  • Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernández MI, Wood CG, Montorsi F, Ströbel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57: 575–581

    PubMed  Google Scholar 

  • Zungri E, Chéchile G, Algaba F, Diaz I, Vilá F, Castro C (1990) Treatment of transitional cell carcinoma of the ureter: is the controversy justified? Eur Urol 17: 276–280

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie, Uroonkologie und Kinderurologie, Universitätsklinikum Essen, Hufelandstraße 55, D-45122, Essen, Deutschland

    S. Tschirdewahn

  2. Marienklinikum Duisburg, HELIOS-Kliniken Duisburg, Wanheimer Straße 167a, D-47053, Duisburg, Deutschland

    F. vom Dorp

  3. Klinik für Urologie, Kinderurologie und Urologische Onkologie, Klinikum Niederberg, Robert-Koch-Straße 2, D-42549, Velbert, Deutschland

    M. Goepel

  4. Urologische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, D-81675, München, Deutschland

    M. Retz

  5. Klinik und Poliklinik für Urologie, Universitätsklinikum Essen, Hufelandstraße 55, D-45122, Essen, Deutschland

    H. Rübben

Authors
  1. S. Tschirdewahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. vom Dorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Goepel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Retz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Rübben
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Urologie, Universitätsklinikum Essen, Essen, Germany

    Herbert Rübben

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tschirdewahn, S., vom Dorp, F., Goepel, M., Retz, M., Rübben, H. (2014). Nierenbecken- und Harnleiterkarzinom. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35032-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35032-0_21

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35031-3

  • Online ISBN: 978-3-642-35032-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation